Home/Filings/4/0001193805-24-000334
4//SEC Filing

Cote Jennifer 4

Accession 0001193805-24-000334

CIK 0001123494other

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 4:04 PM ET

Size

8.8 KB

Accession

0001193805-24-000334

Insider Transaction Report

Form 4
Period: 2024-03-05
Cote Jennifer
Chief Financial Officer
Transactions
  • Tax Payment

    Common Stock

    2024-03-06$4.11/sh9,920$40,771168,738 total
  • Award

    Common Stock

    2024-03-05+35,800142,858 total
  • Award

    Common Stock

    2024-03-05+35,800178,658 total
Footnotes (4)
  • [F1]Shares withheld by the Company solely to cover tax obligations upon the vesting of 29,880 restricted stock units ("RSUs").
  • [F2]Represents an award of RSUs that will vest in three equal installments on March 19, 2025, 2026, and 2027.
  • [F3]The number of RSUs represents the target number of RSUs that may be earned based on achievement by the Company of certain performance criteria. The actual number of RSUs awarded may vary between 0% and 150% of the target, depending on the Company's performance. The performance period will end on December 31, 2026.
  • [F4]Includes (a) the awards described in footnotes (2) and (3) above, (b) 17,928 RSUs that will vest in two equal installments on December 29, 2024 and 2025, (c) 11,171 RSUs that will vest on December 29, 2024, (d) 25,862 RSUs with performance based vesting conditions tied to relative total shareholder return and (e) 42,177 shares of common stock beneficially owned by the Reporting Person.

Issuer

HARVARD BIOSCIENCE INC

CIK 0001123494

Entity typeother

Related Parties

1
  • filerCIK 0001960481

Filing Metadata

Form type
4
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:04 PM ET
Size
8.8 KB